Association between deletion polymorphism of the angiotensin-converting enzyme gene and cerebral atherosclerosis

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 34, Issue 4, 1996, Pages 301-304

  Sertie, Jadranka ^a   Hebrang, Danijela ^b   Janus, Drago ^a   Salzer, Branka ^b   Niksic, Martina ^b   Cvoriscec, Dubravka ^a   Stavljenic Rukavina, Ana ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ALLELES; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE DELETION; GENOTYPE; HOMOZYGOTE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LIPIDS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0029924213     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Warden A, Thompson E. Apolipoprotein E and the development of atherosclerosis. Lab Med 1993; 25:449-55.
2. Erdös E, Skidgel RA. The angiotensin 1-converting enzyme. Lab Invest 1987; 56:345-8.
3. Mercator Study group: Does the new angiotensin converting enzyme inhibitor Cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 1992; 86:100-10.
4. Kurtz WT. The ACE of hearts. Nature 1992; 359:588-9.
5. Ferrario CM. The renin-angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmacol 1990; 15 (Suppl3):Sl-S5.
6. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51:197-205.
7. Jacob H, Lindpaintner K, Lincoln S, Kusumi K, Bunker R, Mao Y, et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 1991 ; 67:213-24.
8. Paul M, Wagner J, Dzau V. Gene expression of the renin-angiotensin system in human tissues. J Clin Invest 1993; 91:2058-64.
9. Zee R, Lou Y, Griffiths L, Morris B. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184:9-15.
10. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-4.
11. Schunkert H, Hense H, Holmer S, Slender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 33:1634-8.
12. Raynold M, Bristow M, Buch E, Abraham W, Lowes B, Zisman L, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342:1073-5.
13. Mulis KF, Fallona T. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987; 155:335.
14. Stavljenic-Rukavina A, Sertie J, Salzer B, Dumic M, Radica A, Fumic K, et al. Apolipoprotein E phenotypes and genotypes as determined by polymerase chain reaction using allele-specific oligonucleotide probes and the amplification mutation system in children with insulin-dependent diabetes mellitus. Clin Chem Acta 1993; 216:191-8.
15. Cushman DW, Cheung HS. Concentration of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 1971; 250:261-5.
16. Salzer B, Stavljenic A, Jürgens G, Dumic M, Radica A. Polymorphism of apolipoprotein E, lipoprotein (a), and other lipoproteins in children with type I diabetes. Clin Chem 1993; 39:1427-32.
17. Zingone A, Dominijanni A, Mele E, Marasco 0, Melina F. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet 1994; 94:207-9.
18. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994; 46:94-101.
19. Lindpaintner K, Pfeffer M, Kreutz R, Stampfer M, Grodstein F. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischémie heart disease. N Engl J Med 1995; 332:11:706-11.